Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Conserved oligomeric Golgi complex subunit 5 (COG5) is a component of the COG complex, an eight-protein assembly crucial for maintaining Golgi apparatus structure and mediating protein and lipid glycosylation. COG5 is centrally involved in the retrograde transport of vesicles within the Golgi apparatus, particularly recycling glycosylation enzymes and ensuring proper protein modification and sorting. It forms part of the lobe B subcomplex (with COG6, COG7, COG8), adopting a CATCHR (Complexes Associated with Tethering Containing Helical Rods) fold that mediates protein-protein interactions vital for vesicle tethering. Mutations in COG5 cause congenital disorders of glycosylation by disrupting Golgi trafficking and glycan processing, leading to developmental, neurological, and multisystem disease[1][2][3][4]. There are currently no known drugs targeting COG5; the gene and its protein product function as an essential vesicle trafficking scaffold rather than a conventional therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Conserved oligomeric Golgi complex subunit 5 (COG5).